EMA guidance supports development of new antibiotics
As part of its efforts to support a global approach to the development of new antimicrobial medicines, EMA has published the final revised guideline...
New Guidelines To Accelerate The Pace of Paediatric Drugs
A new approach for extrapolating clinical trial data using adult research aims to speed up and lower the cost of testing and approval of...
Scientists Uncover Sea Corals That Can Help Fight Cancer
The ocean below is filled with riddles, but scientists have recently discovered one of its best-kept mysteries. For the past 25 years, researchers have...
Dr. Reddys Boasts Strong Russia Sales While Big Pharma Pulls
While many western biopharma businesses have shied away from Russia since its invasion of Ukraine, some of those in India have stepped in to...
Novel Molecular Target For Treatment of Cancer Discovered
The Ohio State University Comprehensive Cancer Center, Richard J. Solove Research Institute, and James Cancer Hospital have discovered a new molecular therapeutic target that...
Commercial Success In New Biopharmaceutical Innovation Era
AmerisourceBergen makes strategic investments, deploys solutions to raise its end-to-end suite of commercialization services, ushering in new monetization era.
The new era in biopharmaceutical development...
In Another Factory Expansion, Catalent Commits $175 Million
Catalent, a manufacturing behemoth, has announced another expansion, this time at a large oral medication plant that had previously doubled in size in 2015....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...